SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Laura M. Kulik, Attasit Chokechanachaisakul, Evaluation and Management of Hepatocellular Carcinoma, Clinics in Liver Disease, 2015, 19, 1, 23

    CrossRef

  2. 2
    Michael Vouche, Riad Salem, Frank H. Miller, M Lemort, Bruno Vanderlinden, Daniel De Becker, Alain Hendlisz, Patrick Flamen, Y90 radioembolization of colorectal cancer liver metastases: response assessment by contrast-enhanced computed tomography with or without PET-CT guidance., Clinical Imaging, 2015,

    CrossRef

  3. 3
    Tushar Patel, Denise Harnois, Assessment of response to therapy in hepatocellular carcinoma, Annals of Medicine, 2014, 46, 3, 130

    CrossRef

  4. 4
    Julius Chapiro, Rafael Duran, Jean-François Geschwind, Combination of intra-arterial therapies and sorafenib: Is there a clinical benefit?, La radiologia medica, 2014, 119, 7, 476

    CrossRef

  5. 5
    Derek M Manas, Hypertrophy in the contralateral lobe post-selective internal radiation therapy, Future Oncology, 2014, 10, 15s, 65

    CrossRef

  6. 6
    Julius Chapiro, Rafael Duran, MingDe Lin, Rüdiger E. Schernthaner, Zhijun Wang, Boris Gorodetski, Jean-François Geschwind, Identifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non–three-dimensional Imaging Markers, Radiology, 2014, 141180

    CrossRef

  7. 7
    Laura Kulik, Michael Vouche, Sean Koppe, Robert J. Lewandowski, Mary F. Mulcahy, Daniel Ganger, Ali Habib, Jennifer Karp, Patrice Al-Saden, Mario Lacouture, Jonathan Cotliar, Michael Abecassis, Talia Baker, Riad Salem, Prospective randomized pilot study of Y90+/−sorafenib as bridge to transplantation in hepatocellular carcinoma, Journal of Hepatology, 2014, 61, 2, 309

    CrossRef

  8. 8
    Julius Chapiro, Laura D. Wood, MingDe Lin, Rafael Duran, Toby Cornish, David Lesage, Vivek Charu, Rüdiger Schernthaner, Zhijun Wang, Vania Tacher, Lynn Jeanette Savic, Ihab R. Kamel, Jean-François Geschwind, Radiologic-Pathologic Analysis of Contrast-enhanced and Diffusion-weighted MR Imaging in Patients with HCC after TACE: Diagnostic Accuracy of 3D Quantitative Image Analysis, Radiology, 2014, 273, 3, 746

    CrossRef

  9. 9
    Daniel Shouval, The emerging questionable benefit of sorafenib as a neo-adjuvant in HCC patients treated with Y-90 radioembolization pending liver transplantation, Journal of Hepatology, 2014, 61, 2, 190

    CrossRef